Effect of Ashwagandha ksheerapaka in Anidra (Primary Insomnia)
Phase 3
- Conditions
- Health Condition 1: F510- Insomnia not due to a substance orknown physiological condition
- Registration Number
- CTRI/2023/10/058249
- Lead Sponsor
- Dr Rushikesh Dilip Chalak
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patient with classical sign & symptoms of Anidra
2.Patient who are fulfilling the American Psychiatric Association (DSM-IV) diagnostic
criteria of Primary Insomnia.
3.Patient with On-going medication of other systemic disorders which does not interfere
with the current course of insomnia will be included in the study.
Exclusion Criteria
1. Patient with Secondary Insomnia.
2.Patient with Alcohol dependency.
3.Patient suffering with major psychiatric disorders and other Systemic disorders.
4.Patient on Hypnotic medications, sedative drugs or any other drugs which causes
drowsiness.
5.Patient with Lactose intolerance.
6.Pregnant and lactating women will be excluded.
7.Patient denying consent.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Effect of trail drug over anidra (primary insomnia) is assessed by the Pittsburgh Sleep Quality index and Patients mental statusTimepoint: 15day, 30 day, 45 day
- Secondary Outcome Measures
Name Time Method Safety of trial drug & adverse drug reaction, aggravation of the symptoms of the symptoms of Anidra (Primary Insomnia).Timepoint: 15day 30day 45day